Terrie Curran - 21 Nov 2022 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: President and Chief Executive, Director
Signature: /s/ Larry Miller, Attorney-in-Fact for Terrie Curran
Issuer symbol: PHAT
Transactions as of: 21 Nov 2022
Net transactions value: -$14,650
Form type: 4
Filing time: 23 Nov 2022, 15:07:34 UTC
Previous filing: 28 Oct 2022
Next filing: 20 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Sale	$14,650	-1,526	-1.8%	$9.60	83,720	21 Nov 2022	Direct	F1
holding	PHAT	Common Stock						2,236	21 Nov 2022	by 401(k)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.59 to $9.90. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.59 to $9.90. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.